STRAGEN specializes in the development and production management of complex low-concentration hormonal products, niche modified release drugs, and conventional release solid dosage forms.
STRAGEN offers expertise in the development and production
of gels and creams.
STRAGEN develops and manages the manufacturing of high-quality parenteral drugs, such as antibiotics and highly potent cytostatic agents. All in collaboration with a scope of carefully selected European CMOs.